High-Throughput Virtual Screening of Proteins Using GRID Molecular Interaction Fields

被引:64
|
作者
Sciabola, Simone [1 ]
Stanton, Robert V. [1 ]
Mills, James E. [2 ]
Flocco, Maria M. [2 ]
Baroni, Massimo [3 ]
Cruciani, Gabriele [4 ]
Perruccio, Francesca [5 ]
Mason, Jonathan S. [6 ]
机构
[1] Pfizer Res Technol Ctr, Cambridge, MA 02139 USA
[2] Pfizer Global Res & Dev, Sandwich CT13 9NJ, Kent, England
[3] Mol Discovery Ltd, Pinner HA5 5NE, Middx, England
[4] Univ Perugia, Lab Chemometr, I-60123 Perugia, Italy
[5] Syngenta, CH-4332 Stein Ag, Switzerland
[6] Lundbeck AS, DK-25000 Copenhagen, Denmark
关键词
RESOLUTION CRYSTAL-STRUCTURE; FAVORABLE BINDING-SITES; COUPLED RECEPTOR; EFFICIENT DETECTION; KINASE INHIBITORS; FUNCTIONAL SITES; LIGAND COMPLEXES; DRUG DESIGN; DATA-BANK; SEQUENCE;
D O I
10.1021/ci9003317
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new computational algorithm for protein binding sites characterization and comparison has been developed, which uses a common reference framework of the projected ligand-space four-point pharmacophore fingerprints, includes cavity shape. and can be used with diverse proteins as no structural alignment is required. Protein binding sites are first described using GRID molecular interaction fields (GRID-MIFs), and the FLAP (fingerprints for ligands and proteins) method is then used to encode and compare this information. The discriminating power of the algorithm and its applicability for large-scale protein analysis was validated by analyzing various scenarios: clustering of kinase protein families in a relevant manner, predicting ligand activity across related targets, and protein-protein Virtual screening. In all cases the results showed the effectiveness of the GRID-FLAP method and its potential use in applications Such as identifying selectivity targets and tools/hits for new targets via the identification of other proteins with pharmacophorically similar binding sites.
引用
下载
收藏
页码:155 / 169
页数:15
相关论文
共 50 条
  • [1] Virtual high-throughput screening of molecular databases
    Seifert, Markus H. J.
    Kraus, Juergen
    Kramer, Bernd
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2007, 10 (03) : 298 - 307
  • [2] High-throughput virtual screening
    Hirata, Shuzo
    Shizu, Katsuyuki
    NATURE MATERIALS, 2016, 15 (10) : 1056 - 1057
  • [3] High-throughput virtual screening
    Shuzo Hirata
    Katsuyuki Shizu
    Nature Materials, 2016, 15 : 1056 - 1057
  • [4] Integration of virtual and high-throughput screening
    Bajorath, F
    NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (11) : 882 - 894
  • [5] Integration of virtual and high-throughput screening
    Jürgen Bajorath
    Nature Reviews Drug Discovery, 2002, 1 : 882 - 894
  • [6] Virtual screening and scaffold hopping based on GRID molecular interaction fields
    Ahlström, MM
    Ridderström, M
    Luthman, K
    Zamora, I
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2005, 45 (05) : 1313 - 1323
  • [7] DOVIS: an implementation for high-throughput virtual screening using AutoDock
    Shuxing Zhang
    Kamal Kumar
    Xiaohui Jiang
    Anders Wallqvist
    Jaques Reifman
    BMC Bioinformatics, 9
  • [8] DOVIS: an implementation for high-throughput virtual screening using AutoDock
    Zhang, Shuxing
    Kumar, Kamal
    Jiang, Xiaohui
    Wallqvist, Anders
    Reifman, Jaques
    BMC BIOINFORMATICS, 2008, 9 (1)
  • [9] High-Throughput parallel blind Virtual Screening using BINDSURF
    Sanchez-Linares, Irene
    Perez-Sanchez, Horacio
    Cecilia, Jose M.
    Garcia, Jose M.
    BMC BIOINFORMATICS, 2012, 13
  • [10] High-Throughput parallel blind Virtual Screening using BINDSURF
    Irene Sánchez-Linares
    Horacio Pérez-Sánchez
    José M Cecilia
    José M García
    BMC Bioinformatics, 13